DNA
Ginkgo Bioworks Holdings, Inc.
Next earnings ≈ Aug 6, 2026 · est. from filing cadence
Last earnings +2.4% on 2026-05-07
$9.97
▲ +2.47%$9.97▲ +16.20%
over 1Y
L $5.48EODHDH $16.14
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.5%
1W+13.8%
1M+12.0%
3M+32.2%
YTD+11.8%
1Y+13.4%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Sell
Revenue fell -25.1% YoY.
Ginkgo Bioworks Holdings, Inc. shows $170M in FY2025 revenue (-25.1% YoY), a -183.8% net margin, and -61.5% ROE.
Sources: SEC EDGAR (CIK 0001830214, latest 10-Q filed 2026-05-07) · EODHD · as of 6/25/2026, 4:03:44 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.